The Bio/Med Investor Network was created in late 2014 to address the need to connect early-stage biomedical, medtech and healthcare-related companies with angel investors interested in advancing technologies in this innovative industry. We are supported by Georgia Bio, the Georgia Research Alliance and each of Georgia's research universities. Investment opportunities outside of Georgia are equally considered.


Bio/Med Investor Network, Inc. is a community-supported angel network that is comprised of high net-worth accredited investors who have joined together to evaluate and make individual investments in early-stage biosciences and certain other healthcare companies. Qualifying individuals are invited to consider becoming a Bio/Med Network member.


We are currently seeking applications from early-stage biomedical, medtech and health IT companies. Our typical investment stage target is from $200,000 to $2,000,000, but companies outside of these stages of fundraising will also be considered. Our highly qualified screening committee will select a limited number of applicants for an opportunity to present to our members at one of our quarterly dinners.